🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out what's new on NCI's websites, including the recently released Cancer Trends Progress Report and our freshly launched NCI Minute. cancer.gov/news-events/ca…

Two separate but complementary studies have identified a new way to classify meningioma, the most common type of #BrainTumor. The system may help predict whether a patient’s tumor will grow back after treatment and may lead to new treatments. cancer.gov/news-events/ca…

Drugs widely used to treat certain autoimmune diseases improved survival for those hospitalized with #COVID19, according to results from a large clinical trial led by NIH. nih.gov/news-events/ne…

A proposed rule prohibiting menthol flavoring is expected to make cigarettes less appealing, lower smoking rates, and reduce diseases and deaths caused by cigarette smoking. cancer.gov/news-events/ca… #TobaccoControl #CancerMoonshot

Researchers from @NCIResearchCtr and Herbert Irving Comprehensive Cancer Center have found that women of African ancestry have higher amounts of a protein called gp78 in their breast cancer tumors compared to women of European descent, leading to worse outcomes. ccr.cancer.gov/news/article/a…

NOW ENROLLING: An NCI #ClinicalTrial will evaluate #immunotherapy and other treatments for recurrent #thymoma and #ThymicCarcinoma. Learn more about the trial. ccr.cancer.gov/news/article/c… @NCIResearchCtr

Men diagnosed with low-risk #ProstateCancer are increasingly opting against immediate treatment and choosing active surveillance, a new study finds. Rates of active surveillance more than doubled between 2014 and 2021. cancer.gov/news-events/ca… UC San Francisco

A new study sheds light on the origin of an aggressive subtype of diffuse large B cell #lymphoma. The findings could help researchers develop more targeted therapies for this form of #BloodCancer. ccr.cancer.gov/news/article/n…

NCI in the News: Can multi-cancer early detection tests save lives? NCI is launching a $75 million, 4-year pilot study to find out. science.org/content/articl… @NCICastle @NCIPrevention News from Science #MCED

New findings from a large clinical trial could help doctors and patients select treatments for relapsed or treatment-resistant Ewing #sarcoma, a rare cancer that forms in bone and the soft tissue surrounding bone. cancer.gov/news-events/ca…

The #ChildhoodCancer Data Initiative has new data from OHSU Knight Cancer Institute on children and AYAs with acute myeloid leukemia. datascience.cancer.gov/news-events/ne… #Data4ChildhoodCancer

People with cancer who take #immunotherapy drugs often develop skin #SideEffects, including itching and painful rashes. New research in mice suggests these side effects may be caused by the immune system attacking new bacterial colonies on the skin. cancer.gov/news-events/ca…

A new study by @nciresearchctr investigators shows how an enzyme can disentangle strands of DNA and RNA. ccr.cancer.gov/news/article/s…

Men with metastatic #melanoma don’t live as long as women, and their tumors are more likely to become resistant to commonly used treatments. A new study may help to explain why. cancer.gov/news-events/ca…

The #immunotherapy drug atezolizumab (Tecentriq) is an additional, or adjuvant, treatment after surgery and chemotherapy for some patients with lung cancer. #LCAM #WorldLungCancerDay cancer.gov/news-events/ca…

NCI researchers are developing an #immunotherapy that involves injecting protein bits from cytomegalovirus (CMV) into tumors. In mice, the treatment shrank tumors and kept them from returning. cancer.gov/news-events/ca… @nciresearchctr

A combination of the targeted drugs dabrafenib (Tafinlar) and trametinib (Mekinist) has been approved for nearly any type of advanced solid tumor with a specific mutation in the BRAF gene. NCI-MATCH #ClinicalTrial data helped to inform the approval. cancer.gov/news-events/ca…

Every person’s cancer is different. There’s no guarantee a given treatment is going to work. But a team of researchers hope to soon offer #oncologists a new tool to guide treatment choices for their patients, based on results from a small study-cancer.gov/news-events/ca… #OncTwitter

Regular visits and calls from community health workers resulted in multiple benefits for those with advanced cancers, from greater use of #PalliativeCare to decreased hospital visits and improved quality of life. Read more from this new study: cancer.gov/news-events/ca… #CancerCare

The fusion protein that drives the growth and survival of some rhabdomyosarcoma tumors relies on the KDM4B enzyme, researchers found. Treating mice with a KDM4B-blocking drug and chemotherapy nearly eliminated rhabdomyosarcoma tumors with this protein. cancer.gov/news-events/ca…